Barclays Maintains Labcorp Holdings at Equal-Weight, Raises Price Target to $380 from $330
Barclays has maintained its Equal-Weight rating on Labcorp Holdings while increasing its price target to $380 from $330.
Stocks · News reference
Morgan Stanley Adjusts Price Target on Labcorp Holdings to $388 From $338
Morgan Stanley has revised its price target for Labcorp Holdings, increasing it to $388 from the previous $338.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Deutsche Bank Adjusts Labcorp Price Target to $355 From $306, Maintains Hold Rating
Deutsche Bank has increased its price target for Labcorp to $355 from $306 while maintaining a Hold rating.
UBS Adjusts Price Target on Labcorp to $420 From $380, Maintains Buy Rating
UBS has raised its price target for Labcorp to $420 from $380 while maintaining a Buy rating.